Foster City, CA, United States of America

Yue Yang

This inventor holds 1 USPTO granted patent and 7 published patent applications. Top assignees: Lawrence Livermore National Security, LLC, Leidos Biomedical Research, Inc., Theras, Inc.. Active years: 2026.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 13.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Yue Yang in Cancer Treatment

Introduction

Yue Yang is an accomplished inventor based in Foster City, CA (US). He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds aimed at treating cancers. His innovative work has led to the filing of a patent that addresses critical health challenges.

Latest Patents

Yue Yang holds a patent for "Compositions and methods for inhibition of RAS." This patent includes compounds, salts, esters, tautomers, prodrugs, zwitterionic forms, or stereoisomers, along with pharmaceutical compositions that utilize these compounds. The methods described in the patent focus on modulating, specifically inhibiting, KRAS, particularly the KRAS G12C mutation, to treat various diseases or disorders, including cancers.

Career Highlights

Throughout his career, Yue Yang has worked with notable organizations such as Leidos Biomedical Research, Inc. and Lawrence Livermore National Security, LLC. His experience in these companies has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Yue has had the opportunity to work alongside talented individuals, including Anna E Maciag and Christopher John Brassard. These collaborations have enriched his research and expanded the impact of his innovations.

Conclusion

Yue Yang's contributions to cancer treatment through his innovative patent demonstrate his commitment to advancing medical science. His work continues to inspire future research and development in the field.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…